In the seminar “Drugs, Vaccines and Coexistence: Toward a Comprehensive Understanding of Population Dynamics in Streptococcus Pneumoniae under Selection by Humans” jointly organised by the Laboratory of Data Discovery for Health (D²4H) and the School of Public Health at The University of Hong Kong (HKU) on November 1, 2024, our Scientific Board member Professor Marc Lipsitch from Harvard T.H. Chan School of Public Health presented his work on streptococcus pneumoniae, exploring its evolution under human-driven selection with the ultimate goal of improving vaccine design and predicting the impacts of vaccine rollout. He also discussed the related issue of how antimicrobial resistance in this species evolves under the pressure of antibiotic use.

Professor Marc Lipsitch is an internationally recognised expert in infectious disease transmission modeling and has been a leading scientific authority in scientific research and public communication during the COVID-19 pandemic. Professor Lipsitch serves as the senior advisor for the Center for Forecasting and Outbreak Analytics at the US Center for Disease Control and Prevention (CDC). He is also an elected member of the American Academy of Microbiology and the National Academy of Medicine, and a member of the Scientific Board of the D²4H.

The seminar was moderated by Professor Kathy Leung, Co-Investigator of the D²4H and Assistant Professor of the HKU School of Public Health.

Seminar Details
Date: November 1, 2024 (Friday)
Time: 11:00 a.m. – 12:00 p.m. (HK Time)